Suppr超能文献

相似文献

1
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Nat Genet. 2013 Dec;45(12):1483-6. doi: 10.1038/ng.2821. Epub 2013 Nov 3.
2
Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1428-35. doi: 10.1245/s10434-014-4351-9. Epub 2015 Jan 14.
3
Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
Histopathology. 2021 Mar;78(4):556-566. doi: 10.1111/his.14252. Epub 2020 Nov 3.
4
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
J Pathol. 2021 Feb;253(2):234-245. doi: 10.1002/path.5584. Epub 2020 Dec 4.
5
SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
BMC Cancer. 2021 Jan 28;21(1):101. doi: 10.1186/s12885-021-07786-9.
6
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
Clin Cancer Res. 2016 Jan 1;22(1):250-8. doi: 10.1158/1078-0432.CCR-15-0373. Epub 2015 Jul 13.
7
Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
Horm Metab Res. 2015 Jun;47(6):452-5. doi: 10.1055/s-0034-1389992. Epub 2014 Oct 29.
8
Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
Endocr Relat Cancer. 2016 Feb;23(2):93-100. doi: 10.1530/ERC-15-0442. Epub 2015 Nov 24.
9
Genetics and epigenetics in small intestinal neuroendocrine tumours.
J Intern Med. 2016 Dec;280(6):584-594. doi: 10.1111/joim.12526. Epub 2016 Jun 16.
10
Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
Neuroendocrinology. 2017;104(3):302-312. doi: 10.1159/000446917. Epub 2016 May 25.

引用本文的文献

3
Basic science and translational implications of current knowledge on neuroendocrine tumors.
J Clin Invest. 2025 Mar 3;135(5):e186702. doi: 10.1172/JCI186702.
4
p27 and Tumors: Characterization of Variants Identified in MEN4 and Breast Cancer.
Cells. 2025 Jan 26;14(3):188. doi: 10.3390/cells14030188.
5
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.
Endocr Oncol. 2024 Dec 19;4(1):e240055. doi: 10.1530/EO-24-0055. eCollection 2024 Jan 1.
8
Multifaceted modeling of small intestinal neuroendocrine tumors.
Endocr Oncol. 2024 Nov 20;4(1):e240038. doi: 10.1530/EO-24-0038. eCollection 2024 Jan 1.
9
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors.
Curr Oncol Rep. 2024 Nov;26(11):1530-1542. doi: 10.1007/s11912-024-01610-w. Epub 2024 Oct 28.
10
Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment.
Front Endocrinol (Lausanne). 2024 Sep 30;15:1424839. doi: 10.3389/fendo.2024.1424839. eCollection 2024.

本文引用的文献

1
Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.
Oncologist. 2013 Jun;18(6):667-74. doi: 10.1634/theoncologist.2012-0350. Epub 2013 May 30.
2
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Nat Biotechnol. 2013 Mar;31(3):213-9. doi: 10.1038/nbt.2514. Epub 2013 Feb 10.
3
Outcome of surgery for ileojejunal neuroendocrine tumors.
Surg Today. 2013 Oct;43(10):1168-74. doi: 10.1007/s00595-012-0408-1. Epub 2012 Nov 11.
4
Comprehensive molecular portraits of human breast tumours.
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
5
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Cell. 2012 Sep 14;150(6):1107-20. doi: 10.1016/j.cell.2012.08.029.
6
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
Nat Genet. 2012 Oct;44(10):1111-6. doi: 10.1038/ng.2405. Epub 2012 Sep 2.
7
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
Nat Genet. 2012 Oct;44(10):1104-10. doi: 10.1038/ng.2396. Epub 2012 Sep 2.
8
Sequence analysis of mutations and translocations across breast cancer subtypes.
Nature. 2012 Jun 20;486(7403):405-9. doi: 10.1038/nature11154.
9
The landscape of cancer genes and mutational processes in breast cancer.
Nature. 2012 May 16;486(7403):400-4. doi: 10.1038/nature11017.
10
Recurrent hemizygous deletions in cancers may optimize proliferative potential.
Science. 2012 Jul 6;337(6090):104-9. doi: 10.1126/science.1219580. Epub 2012 May 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验